SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-026300
Filing Date
2020-09-24
Accepted
2020-09-24 19:44:58
Documents
2
Period of Report
2020-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14033
2 EX-24 DOCUMENT attachment1.htm EX-24 4087
  Complete submission text file 0000899243-20-026300.txt   19616
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANELIXIS THERAPEUTICS, INC. 1500 DISTRICT AVENUE BURLINGTON MA 01803
Business Address
Perrin Steven (Reporting) CIK: 0001824545 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36620 | Film No.: 201196573